Oregon Green™ 488 Maleimide

Citations & References (25)

Invitrogen™

Oregon Green™ 488 Maleimide

チオール反応性Oregon Green™ 488マレイミドを使用して、最大励起／最大発光波長が約496/524 nmの緑色蛍光バイオコンジュゲートを作成できます。フルオレセインのこのフッ化アナログは、フルオレセインの重大な制限のいくつかを克服し、光安定性の向上やpKaの低減（フルオレセインの6.4に対して約4.7のpKa）などを実現しています詳細を見る

製品番号（カタログ番号）	数量
O6034	5 mg

製品番号（カタログ番号） O6034

価格（JPY）

38,500

キャンペーン価格

Ends: 27-Mar-2026

64,200

割引額 25,700 (40%)

お問い合わせください ›

チオール反応性Oregon Green™ 488マレイミドを使用して、最大励起／最大発光波長が約496/524 nmの緑色蛍光バイオコンジュゲートを作成できます。
フルオレセインのこのフッ化アナログは、フルオレセインの重大な制限のいくつかを克服し、光安定性の向上やpK_aの低減（フルオレセインの6.4に対して約4.7のpK_a）などを実現しています。これにより、生理学的な範囲のpHであれば、その影響をほとんど受けない蛍光性が得られます。

研究用にのみ使用できます。診断用には使用いただけません。

化学反応性チオール

発光524

励起496

標識または色素Oregon Green™ 488

製品タイプマレイミド

数量5 mg

反応性部分マレイミド

出荷条件室温

標識タイプ従来の色素

製品ラインOregon Green

Unit SizeEach

組成および保存条件

フリーザー(-5∼-30度)に保存し、遮光してください。

引用および参考文献 (25)

引用および参考文献

Abstract

Effect of the substitution of muscle actin-specific subdomain 1 and 2 residues in yeast actin on actin function.

Authors:McKane M, Wen KK, Meyer A, Rubenstein PA

Journal:J Biol Chem

PubMed ID:16882670

'Muscle and yeast actins display distinct behavioral characteristics. To better understand the allosteric interactions that regulate actin function, we created a muscle/yeast hybrid actin containing a muscle-specific outer domain (subdomains 1 and 2) and a yeast inner domain (subdomains 3 and 4). Actin with muscle subdomain 1 and the two ... More

Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine.

Authors:Qiu H, Edmunds T, Baker-Malcolm J, Karey KP, Estes S, Schwarz C, Hughes H, Van Patten SM

Journal:J Biol Chem

PubMed ID:12801930

'One form of Niemann-Pick disease is caused by a deficiency in the enzymatic activity of acid sphingomyelinase. During efforts to develop an enzyme replacement therapy based on a recombinant form of human acid sphingomyelinase (rhASM), purified preparations of the recombinant enzyme were found to have substantially increased specific activity if ... More

A pathway of structural changes produced by monastrol binding to Eg5.

Authors:Maliga Z, Xing J, Cheung H, Juszczak LJ, Friedman JM, Rosenfeld SS

Journal:J Biol Chem

PubMed ID:16434397

'Monastrol is a small molecule inhibitor that is specific for Eg5, a member of the kinesin 5 family of mitotic motors. Crystallographic models of Eg5 in the presence and absence of monastrol revealed that drug binding produces a variety of structural changes in the motor, including in loop L5 and ... More

A fluorescent glycolipid-binding peptide probe traces cholesterol dependent microdomain-derived trafficking pathways.

Authors:Steinert S, Lee E, Tresset G, Zhang D, Hortsch R, Wetzel R, Hebbar S, Sundram JR, Kesavapany S, Boschke E, Kraut R,

Journal:PLoS ONE

PubMed ID:18716682

'BACKGROUND: The uptake and intracellular trafficking of sphingolipids, which self-associate into plasma membrane microdomains, is associated with many pathological conditions, including viral and toxin infection, lipid storage disease, and neurodegenerative disease. However, the means available to label the trafficking pathways of sphingolipids in live cells are extremely limited. In order ... More

Structure-function relationships in OxlT, the oxalate/formate transporter of Oxalobacter formigenes. Topological features of transmembrane helix 11 as visualized by site-directed fluorescent labeling.

Authors:Fu D, Maloney PC

Journal:J Biol Chem

PubMed ID:9651403

'Analysis of hydropathy suggests that in OxlT, the oxalate/formate antiporter of Oxalobacter formigenes, lysine 355 is within transmembrane helix no. 11. To test this idea, we used single-cysteine, histidine-tagged OxlT variants to study the organization of a 30-residue segment (residues 344-373) containing this region. Topology was examined by probing the ... More

View all Oregon Green™ 488 Maleimide citations